Evonik expands lipid-based drug delivery capabilities with new GMP manufacturing facility in Vancouver
ESSEN, Germany, Aug. 28, 2026 /PRNewswire/ — Evonik is investing in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada. The facility will increase Evonik’s development and
